poisar

Stocks · News reference

This Definium Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

BenzingaAvi Kapoor

Top analysts changed outlook on top names. See analyst ratings page for all changes.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
benzinga
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading

  1. Globenewswire IncNa

    KANZHUN LIMITED Declares Annual Cash Dividend and Shareholder Return Plan

    BOSS Zhipin (KANZHUN LIMITED) announced an annual cash dividend of US$0.255 per ordinary share (US$0.510 per ADS), totaling approximately US$230 million. The dividend will be paid to shareholders of record as of September 28, 2026, with payment expected in October 2026. The company's CEO highlighted that combined with over US$300 million in share repurchases completed year-to-date, total shareholder returns have exceeded 100% of the prior year's adjusted net income.

  2. Globenewswire IncNa

    BOSS Zhipin Reports Accelerated Second-Quarter Growth and Strengthened Shareholder Returns

    BOSS Zhipin (KANZHUN LIMITED) reported Q2 2026 revenues of RMB2,399 million, up 14.1% year-on-year with accelerating growth. Operating income surged 32.6% while costs grew only 6.1%, demonstrating operational leverage. The platform reached 70.2 million monthly active users and 7.2 million paying enterprise customers. The company announced over US$530 million in combined dividends and share repurchases, committing to allocate at least 50% of adjusted net income annually to shareholder returns.